These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27417323)

  • 41. The patient with chronic ischemic heart disease. Role of ranolazine in the management of stable angina.
    Di Monaco A; Sestito A
    Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1611-36. PubMed ID: 23161033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
    Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ranolazine (Ranexa) for chronic stable angina.
    Ndegwa S
    Issues Emerg Health Technol; 2007 Jun; (99):1-6. PubMed ID: 17595750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
    Camici PG; Gloekler S; Levy BI; Skalidis E; Tagliamonte E; Vardas P; Heusch G
    Int J Cardiol; 2016 Jul; 215():1-6. PubMed ID: 27104917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concomitant Use of Ranolazine and Trimetazidine in Patients with Refractory Angina: An Initial Experience.
    Dourado LOC; Moreno CPD; Grobe SF; Gowdak LHW; Cesar LAM
    Arq Bras Cardiol; 2022 Oct; 119(4):619-621. PubMed ID: 35946755
    [No Abstract]   [Full Text] [Related]  

  • 46. Old and New Drugs for Treatment of Stable Angina.
    Rognoni A
    Cardiovasc Hematol Agents Med Chem; 2015; 13(1):3. PubMed ID: 26245657
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical experience with ranolazine in a veteran population with chronic stable angina.
    Reeder DN; Gillette MA; Franck AJ; Frohnapple DJ
    Ann Pharmacother; 2012 Jan; 46(1):42-50. PubMed ID: 22215689
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina--the VASCO-angina study.
    Vitale C; Spoletini I; Malorni W; Perrone-Filardi P; Volterrani M; Rosano GM
    Int J Cardiol; 2013 Sep; 168(2):1078-81. PubMed ID: 23200272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-anginal and anti-ischemic effects of late sodium current inhibition.
    Wimmer NJ; Stone PH
    Cardiovasc Drugs Ther; 2013 Feb; 27(1):69-77. PubMed ID: 23247666
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.
    Porres-Aguilar M; Muñoz OC; Abbas A
    Curr Cardiol Rep; 2016 Feb; 18(2):13. PubMed ID: 26768739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
    Chaitman BR
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S47-64. PubMed ID: 15378131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A literature review to evaluate the economic value of ranolazine for the symptomatic treatment of chronic angina pectoris.
    Vellopoulou K; Kourlaba G; Maniadakis N; Vardas P
    Int J Cardiol; 2016 May; 211():105-11. PubMed ID: 26994453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging drugs for the treatment of angina pectoris.
    Chong CR; Ong GJ; Horowitz JD
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):365-376. PubMed ID: 27686005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ranolazine: a better understanding of its pathophysiology and patient profile to guide treatment of chronic stable angina.
    Tamargo J; Lopez-Sendon J
    Future Cardiol; 2022 Mar; 18(3):235-251. PubMed ID: 34841884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimal Medical Therapy for Stable Ischemic Heart Disease: Focus on Anti-anginal Therapy.
    Montelaro BM; Ibrahim R; Thames M; Mehta PK
    Med Clin North Am; 2024 May; 108(3):455-468. PubMed ID: 38548457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
    Oh PC; Kang WC; Moon J; Park YM; Kim S; Kim MG; Lee K; Ahn T; Shin EK
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):221-8. PubMed ID: 27021556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A New Insight on Anti-Ischemic Action of Ivabradine in Patients With Stable Angina].
    Kobalava ZD; Shavarov AA; Kiyakbaev GK
    Kardiologiia; 2017 Mar; 57(3):68-74. PubMed ID: 28762939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Ranolazine in the treatment of chronic stable angina].
    Gustapane M; Cardillo MT; Biasillo G; Della Bona R
    Clin Ter; 2012; 163(3):231-4. PubMed ID: 22964698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ranolazine: a new option in the management of chronic stable angina.
    Dobesh PP; Trujillo TC
    Pharmacotherapy; 2007 Dec; 27(12):1659-76. PubMed ID: 18041887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.